Target intelligence / Profile preview

Microbial and fungal cell membrane

Molecular classification
Cell membrane, Lipid bilayer
01

Overview

The microbial and fungal cell membrane is a fundamental lipid bilayer structure that maintains cellular homeostasis by regulating the transport of ions and nutrients. In bacteria, the cytoplasmic membrane is the site of essential processes such as the electron transport chain and ATP synthesis, while in fungi, the plasma membrane is characterized by the presence of ergosterol, a sterol absent in animal cells (StatPearls, 2023). These membranes serve as vital therapeutic targets because their unique composition allows for selective toxicity against pathogens. For instance, polyene antifungals like amphotericin B bind to ergosterol to form lethal pores, while lipopeptide antibiotics like daptomycin insert into bacterial membranes to cause rapid depolarization (NIH, 2022). Disruption of membrane integrity leads to the leakage of essential cytoplasmic components, resulting in rapid cell death. However, the similarity between certain microbial lipids and human cell components can lead to significant safety concerns, such as the nephrotoxicity associated with polymyxins and polyenes (PubMed, 2021).

Other names
Bacterial cytoplasmic membraneFungal plasma membraneMicrobial lipid bilayerProkaryotic cell membrane
02

Mechanism of action

Drugs targeting these membranes typically act through direct membrane disruption via pore formation, depolarization of the membrane potential, or by inhibiting the biosynthesis of essential membrane components like ergosterol, leading to loss of structural integrity and cell lysis (StatPearls, 2023; NIH, 2022).

03

Biological functions

Selective permeabilityIon homeostasisEnergy metabolismSignal transductionCell wall biosynthesis
04

Disease associations

Bacterial infectionFungal infectionSepsisMycosis
05

Safety considerations

NephrotoxicityNeurotoxicityInfusion-related reactionsPotential for cross-reactivity with mammalian cholesterol-containing membranes
06

Interacting drugs

Amphotericin B

8 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)Ergosterol contentMembrane potential changes

Beyond the preview

Go deeper on Microbial and fungal cell membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial and fungal cell membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call